Showing 43,821 - 43,840 results of 44,841 for search '(( 50 ((c decrease) OR (a decrease)) ) OR ( 5 ((ppm decrease) OR (mean decrease)) ))', query time: 1.34s Refine Results
  1. 43821
  2. 43822
  3. 43823
  4. 43824
  5. 43825
  6. 43826
  7. 43827
  8. 43828
  9. 43829

    Table_1_Clinical features, immunologic parameter and treatment outcome of Chinese tuberculosis patients with or without DM.DOCX by Fengjun Tong (18809563)

    Published 2024
    “…Background<p>The coexistence of diabetes mellitus (DM) and pulmonary tuberculosis (PTB) poses a significant health concern globally, with their convergence presenting a considerable challenge to healthcare systems. …”
  10. 43830

    Table_1_Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis.DOCX by Mariapaola Marino (784475)

    Published 2020
    “…Optimal response to RTX was defined as the achievement and maintenance of the status of minimal manifestations (MM)-or-better together with a50% steroid reduction, withdrawal of immunosuppressants, and no need for plasma-exchange or intravenous immunoglobulin. …”
  11. 43831

    Biomarker Benchmark - GSE37199 by Anna Guyer (1390293)

    Published 2016
    “…LPD 1 membership remained the strongest prognostic factor in a multivariate analysis (HR 5.0, CI-95% 2.1-11.9, p=0.0002). …”
  12. 43832

    Activity of mice during CR. by Gino Boily (88104)

    Published 2013
    “…<p>Total activity of normal (A) and SirT1-null (B) mice was monitored using a Micromax system for 24-hour periods at the indicated time after the start of CR. Animals were 5–7 months old at the beginning of CR. Means and standard errors are represented. …”
  13. 43833

    Data_Sheet_1_Burden and trends of stroke attributable to dietary risk factors from 1990 to 2019 in the Belt and Road Initiative countries: an analysis from the global burden of dis... by Yue Zhang (30585)

    Published 2023
    “…The ASR of DALYs for diet-induced stroke decreased greater in females than in males. For those aged 50–74, the DALYs for stroke due to dietary risk factors in all other member countries of the “B&R” showed a decreasing trend, except for the Philippines, which rose (AAPC = 2.13, 95%CI: 1.40–2.87%) and Turkmenistan, which remained stable (AAPC = 0.05, 95%CI: −0.43–0.33%).…”
  14. 43834

    Sleep Duration and Cancer in the NIH-AARP Diet and Health Study Cohort by Fangyi Gu (266663)

    Published 2016
    “…A decreased ovarian cancer risk (HR<sub>≥ 9 vs. 7–8 hours</sub> = 0.50; 95%CI:0.26–0.97) and an increased NHL risk (HR<sub>≥ 9 vs. 7–8 hours</sub> = 1.45; 95%CI:1.00–2.11) were observed among long sleepers.…”
  15. 43835

    Table 4_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  16. 43836

    Supplementary file 1_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  17. 43837

    Table 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  18. 43838

    Table 1_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  19. 43839

    Table 3_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  20. 43840

    Table 7_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”